View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
December 17, 2021updated 11 Jul 2022 2:15pm

SureClinical unveils Eclinical Ecosystem ECO Bundle for trial automation

ECO Bundle aids users to select and link applications to a single system of record, lowering risk and operational expenses.

Cloud-native eClinical applications provider SureClinical has introduced its new Eclinical Ecosystem ECO Applications and Platform Bundle for clinical trial automation and collaboration.

Free Case Study
img

Direct-to-Patient Trials: How IRT Plays an Important Role in Bellerophon's Direct-to-Patient Trials

As the industry strengthens its focus on patient centricity, Direct-to-Patient clinical trials have emerged as a popular trial design that have the potential to increase patient recruitment and retention. IRT plays a crucial role in the success of a Direct-to-Patient trial. Because drug supplies are being managed and shipped from distribution facilities directly to patients’ homes, a sponsor must have a high-quality system in place to accurately track the chain of custody, ensure patient-blinding and handle other logistical challenges. What You Will Learn Benefits and challenges associated with the Direct-to-Patient model Bellerophon's top considerations when implementing this trial design How IRT can equip study teams to successfully track chain of custody, ensure patient blinding, and handle logistical challenges
by Suvoda
Enter your details here to receive your free Case Study.

The ECO Bundle is intended to cater to the unique requirements of clinical research organisations and connects people, programmes, projects and processes worldwide for a single view of clinical data.

It unifies clinical intelligence and reporting across numerous apps, systems and data points, permitting scattered clinical research groups to cooperate within a single, advanced, user-friendly application.

Throughout the complete trial supply chain, SureClinical’s service links internal teams and external vendors.

The bundle gives users the opportunity to choose and link their preferred applications to a single system of record, lowering the risk and operational expenses.

This approach also boosts business reporting efficiency and equips teams with automated solutions to digitise and simplify the trial process.

SureClinical CEO Zack Schmidt said: “With growing regulatory guidance, recent market conditions, and the impact of the global pandemic, pharmaceutical companies seek digital solutions to connect end-to-end eClinical systems, disparate teams, systems and projects in a timely manner to enhance their treatment quality and reduce business risk.

“The ECO Bundle answers that need, providing sponsors and CROs with automated tools that are connectable, accessible, extensible and that can be deployed in one day.”

The ecosystem aids in managing projects, documents, trial sites, and quality levels.

The company’s clinical trial management system, SureCTMS, which is part of the ECO Bundle, connects to any enterprise application, database, Investigator Site File, electronic Trial Master File, Quality Management Software and Clinical Trial Management applications.

This October, Pacific Cancer Care entered a partnership to use Deep Lens’ AI-based solutions to simplify trial matching and expedite enrolment of cancer patients.

Related Companies

Free Case Study
img

Direct-to-Patient Trials: How IRT Plays an Important Role in Bellerophon's Direct-to-Patient Trials

As the industry strengthens its focus on patient centricity, Direct-to-Patient clinical trials have emerged as a popular trial design that have the potential to increase patient recruitment and retention. IRT plays a crucial role in the success of a Direct-to-Patient trial. Because drug supplies are being managed and shipped from distribution facilities directly to patients’ homes, a sponsor must have a high-quality system in place to accurately track the chain of custody, ensure patient-blinding and handle other logistical challenges. What You Will Learn Benefits and challenges associated with the Direct-to-Patient model Bellerophon's top considerations when implementing this trial design How IRT can equip study teams to successfully track chain of custody, ensure patient blinding, and handle logistical challenges
by Suvoda
Enter your details here to receive your free Case Study.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena